Eyam Vaccines and Immunotherapeutics: Eyam Vaccines And Immunotherapeutics Embarks On New Licensing Agreement For Creating Innovative Vaccine Technologies

VANCOUVER, BC / ACCESSWIRE / August 3, 2022 / Eyam Vaccines and Immunotherapeutics (Eyam), has announced a new licensing agreement for innovative vaccine technologies from the University of British Columbia

Related Keywords

Canada ,United Kingdom ,Vancouver ,British Columbia ,Edinburgh ,City Of ,Scotland ,British ,Kostenloser Wertpapierhandel ,Ryan Thomas ,Paolo Ribeca ,Immunotherapeutics Eyam ,Wilfred Jefferies ,University Of British Columbia ,James Hutton Institute ,Eyam Vaccines ,Professor Wilfred Jefferies ,Michael Smith Laboratories ,Statistics Scotland ,Chief Executive ,Professor Jefferies ,Medical Genetic ,Chief Scientific Officer ,Principal Bioinformatician ,Viral Vectors ,Eyam ,Vaccines ,Immunotherapeutics ,Embarks ,Icensing ,Agreement ,Reating ,Nnovative ,Vaccine ,Technologies ,